$31.59
Today
as of Jul 22, 16:55 ET
Last 30 days
Recent Press Releases & News
Tectonic Therapeutic Completes Enrollment in in Phase 2 Trial of TX45
Tectonic Therapeutic Completes Enrollment in TX45 APEX Phase 2 Clinical Trial in PH-HFpEF Patients
Tectonic Therapeutic Shares Rise After Raymond James Upgrade
Overview
52-week range
$14
$36
79% of range
Avg surprise (last 3)
-3.1%
Avg reaction (last 2)
+1.7%
50% positive
Latest IV / EM
122%
EM ±27.9% · $30 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 7, 2026 | Mar/2026 | $-1.34 | $-1.16 | -15.5% | -44.1% | -7.4% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-1.02 | — | — | — | — | financials |
| Thu Aug 7, 2025 | Jun/2025 | $-1.07 | $-0.98 | -9.2% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $-0.93 | $-1.10 | +15.4% | — | +10.8% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-1.20 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-4.34 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-10.97 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-7.62 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-8.51 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Aug 6, 2026 | Jun/2026 | OTHER | -$1.40 | -$1.07 | -30.8% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-27M | — | $-22M | $-22M | $-18M | — | $-20M | $-11M |
| Net income | $-25M | — | $-19M | $-20M | $-16M | — | $-18M | $-13M |
| EPS (diluted) | $-1.34 | — | $-1.02 | $-1.07 | $-0.93 | — | $-1.20 | $-4.34 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $237M | $254M | $268M | $287M | $306M | $141M | $159M | $185M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $240M | $257M | $273M | $291M | $310M | $147M | $163M | $187M |
| Total assets | $247M | $261M | $277M | $295M | $315M | $153M | $169M | $194M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $16M | $10M | $9M | $12M | $14M | $12M | $18M | $28M |
| Total equity | $230M | $251M | $268M | $284M | $301M | $141M | $150M | $166M |